Brief: Axial3D Receives FDA Clearance For Axial3D Insight Medical Image Segmentation Platform
July 31 (Reuters) - Stratasys Ltd SSYS.O :
* AXIAL3D RECEIVES FDA CLEARANCE FOR AXIAL3D INSIGHT™
MEDICAL
IMAGE SEGMENTATION PLATFORM
Source text for Eikon: ID:nBw3V0Rxma
Further company coverage: SSYS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stratasys
See all newsBrief: Stratasys And Limbitless Solutions Expand Ongoing Partnership Providing Access To 3D-Printed Prosthetics For Children
Stratasys Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's Stratasys Q2 profit beats on aerospace, defense segment growth
Brief: Stratasys - Awarded $7.80 Million Funding Through 2026 America Makes And Department Of War Challenge
Stratasys Ltd expected to post earnings of 1 cent a share - Earnings Preview